key: cord-0859486-br88sp8b
authors: Öncü, I.N.S.; Güler, D.; Gürel, G.; Yalçın, G.Ş.
title: Pityriasis Rosea in a Confirmed COVID-19 Pediatric Patient()
date: 2021-07-14
journal: Actas Dermosifiliogr
DOI: 10.1016/j.adengl.2021.07.006
sha: 59c0e8986ac13d701ae374b6367c70d32d76f764
doc_id: 859486
cord_uid: br88sp8b

nan

Autor para correspondencia: Işın Nur Sultan Öncü reported. Among these, Pityriasis rosea (PR) and PR-like rash have been published previously. During the COVID-19 pandemic, the diagnosis of PR has become more common. 1, 2, 3, 4, 5 PR is a self-limited inflammatory skin disease that can be induced viral agents especially HHV-6 (Human herpes virus 6), HHV-7 (Human herpes virus 7), autoimmunity, psychogenic factors, vaccines and drugs. 1, 2 We present here a case of PR in a a confirmed COVID-19 pediatric patient A 10-year-old boy presented with a 20-day history of skin rash. It was learned that he had 

The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease

Pityriasis rosea-like eruption revealing COVID

Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19

Pityriasis rosea and COVID-19

Pityriasis rosea in otherwise asymptomatic confirmed COVID-19-positive patients: A report of 2 cases